Menzies School of Health Research, Darwin, Australia.
Baker Heart and Diabetes Institute, Melbourne, Australia.
Diabet Med. 2017 Jul;34(7):946-957. doi: 10.1111/dme.13360. Epub 2017 May 15.
To assess the relationships of diabetes and albuminuria with all-cause mortality and cardiovascular disease outcomes in a population without prior cardiovascular disease using data from the Darwin Region Urban Indigenous Diabetes (DRUID) study.
We conducted a prospective cohort study of 706 participants (aged 15-81 years, 68% women) without prior cardiovascular disease who underwent a 75-g oral glucose tolerance test. Deaths and fatal or non-fatal cardiovascular disease were determined over 7 years, and hazard ratios with 95% CIs and population attributable risks were estimated for baseline glycaemia and albuminuria.
Compared with normoglycaemia and after adjustment for age, sex, hypertension, dyslipidaemia and smoking, known diabetes was associated with an adjusted hazard ratio of 4.8 (95% CI 1.5-14.7) for all-cause mortality and 5.6 (95% CI 2.1-15.2) for cardiovascular disease. Compared with normoalbuminuria, the respective adjusted risks for macroalbuminuria were 10.9 (95% CI 3.7-32.1) and 3.9 (95% CI 1.4-10.8). The Adjusted all-cause mortality and cardiovascular disease estimated population attributable risks for diabetes were 27% and 32%, and for albuminuria they were 32% and 21%, respectively.
In our study population, the burden of mortality and cardiovascular disease was largely driven by diabetes and albuminuria. This finding on the influence of diabetes and albuminuria is consistent with reports in other high-risk Indigenous populations and should be better reflected in risk scores and intervention programmes.
利用达尔文地区城市原住民糖尿病(DRUID)研究的数据,在无既往心血管疾病的人群中,评估糖尿病和白蛋白尿与全因死亡率及心血管疾病结局的关系。
我们对 706 名(年龄 15-81 岁,68%为女性)无既往心血管疾病的参与者进行了前瞻性队列研究,这些参与者接受了 75g 口服葡萄糖耐量试验。在 7 年内确定了死亡和致死性或非致死性心血管疾病的发生情况,并估计了基线血糖和白蛋白尿与全因死亡率和心血管疾病的风险比(95%CI 和人群归因风险)。
与血糖正常者相比,在调整年龄、性别、高血压、血脂异常和吸烟因素后,已知糖尿病与全因死亡率的调整风险比为 4.8(95%CI 1.5-14.7),与心血管疾病的调整风险比为 5.6(95%CI 2.1-15.2)。与正常白蛋白尿相比,微量白蛋白尿的相应调整风险分别为 10.9(95%CI 3.7-32.1)和 3.9(95%CI 1.4-10.8)。糖尿病的全因死亡率和心血管疾病估计人群归因风险分别为 27%和 32%,白蛋白尿的全因死亡率和心血管疾病估计人群归因风险分别为 32%和 21%。
在我们的研究人群中,死亡率和心血管疾病的负担主要由糖尿病和白蛋白尿引起。这一发现表明糖尿病和白蛋白尿的影响与其他高危原住民人群的报告一致,应该在风险评分和干预计划中得到更好的反映。